We are live on ! Find out more
EWM

Essex Woodlands Management Portfolio holdings

AUM $254M
1-Year Est. Return 4.59%
This Fund
S&P 500
This Quarter Est. Return
-25.76%
1 Year Est. Return
+4.59%
3 Year Est. Return
+54.96%
5 Year Est. Return
+25.37%
10 Year Est. Return
+254.56%
AUM
$451M
AUM Growth
-$226M
Cap. Flow
-$21M
Cap. Flow %
-4.67%
Top 10 Hldgs %
100%
Holding
9
New
–
Increased
1
Reduced
1
Closed
–

Top Buys

Rank Stock Value
1
TELA icon
TELA Bio
TELA
+$3.54M

Top Sells

Rank Stock Value
1
RVNC
Revance Therapeutics, Inc.
RVNC
+$24.6M

Sector Composition

Rank Sector Weight
1 Healthcare 100%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
BVS icon
1
Bioventus
BVS
$1.17B
$171M 38.01%
12,096,702
– –
MDXG icon
2
MiMedx Group
MDXG
$624M
$142M 31.43%
23,376,623
– –
EYPT icon
3
EyePoint Inc
EYPT
$1.17B
$43.7M 9.69%
4,190,921
– –
VERO
4
DELISTED
Venus Concept
VERO
$31.2M 6.92%
75,260
– –
TELA icon
5
TELA Bio
TELA
$32.3M
$25.1M 5.56%
1,833,989
+253,900
+16% +$3.54M
AXGN icon
6
Axogen
AXGN
$2.67B
$20.2M 4.48%
1,276,645
– –
RVNC
7
DELISTED
Revance Therapeutics, Inc.
RVNC
$13.2M 2.92%
472,590
-861,102
-65% -$24.6M
MNOV icon
8
MediciNova
MNOV
$65.5M
$4.19M 0.93%
1,105,941
– –
GYRE icon
9
Gyre Therapeutics
GYRE
$706M
$323K 0.07%
10,483
– –

Similar funds

TSM
Two Star Manager Miami Beach, Florida $254M AUM 3.61% 1-Year Est. Return
IGM
Incline Global Management New York $255M AUM 7.23% 1-Year Est. Return
WWM
Westwood Wealth Management Los Angeles, California $255M AUM 54.97% 1-Year Est. Return
MWM
MorganRosel Wealth Management Highlands Ranch, Colorado $254M AUM 18.87% 1-Year Est. Return
LRIC
Long Road Investment Counsel Kalamazoo, Michigan $255M AUM 12.85% 1-Year Est. Return
2
2Xideas Kusnacht, Switzerland $255M AUM 0.46% 1-Year Est. Return
ACM
Avos Capital Management Seattle, Washington $253M AUM 13.56% 1-Year Est. Return
KAM
Krensavage Asset Management New York $256M AUM 69.63% 1-Year Est. Return

Essex Woodlands Management's Q3 2021 Portfolio in Review

As of Q3 2021, Essex Woodlands Management held 9 positions worth $451M, down 33% from $677M the previous quarter. Its ten largest holdings account for 100% of the portfolio.

Essex Woodlands Management withdrew a net $21M in Q3 2021, reducing 1 holding. Its largest reduction was Revance Therapeutics, Inc., cutting an estimated $24.6M.

By sector, the portfolio is most concentrated in Healthcare at 100% of assets, unchanged from a quarter earlier.

Against the trend, Essex Woodlands Management added an estimated $3.54M to TELA Bio.

  • Essex Woodlands Management added most to TELA Bio in Q3 2021, an estimated $3.54M increase.
  • Essex Woodlands Management's biggest Q3 2021 reduction was Revance Therapeutics, Inc., cutting an estimated $24.6M.
  • Essex Woodlands Management's ten largest holdings make up 100% of its $451M portfolio in Q3 2021.
  • Essex Woodlands Management opened 0 new positions and closed 0 in Q3 2021.
  • Essex Woodlands Management's portfolio value fell 33% quarter-over-quarter to $451M.

Based on Essex Woodlands Management's 13F filing for Q3 2021, filed 15 Nov 2021.